Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.03 +0.26 (+0.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Preferred Stock Liabilities (2021)

Updated

Amylyx Pharmaceuticals' Preferred Stock Liabilities was $239.35 million in Q4 2021, unchanged from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Preferred Stock Liabilities (2021) Analysis & Trends

From Q1 2021 onward, Amylyx Pharmaceuticals has reported Preferred Stock Liabilities for 4 quarters.

  • Per Business Quant data, AMLX's Preferred Stock Liabilities in the three quarters before Q4 2021 was $239.35 million (Q3 2021), $72.06 million (Q2 2021) and $72.06 million (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Amylyx Pharmaceuticals 3.24 Bn 2.05 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 239.35 Mn
Sep 30, 2021 239.35 Mn
Jun 30, 2021 72.06 Mn
Mar 31, 2021 72.06 Mn
API Access

Amylyx Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=AMLX&period=max&api_key=YOUR_API_KEY